Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-06-15 Paul Robert Chief Medical Officer Sale −3,909 $29.90 $117K 223,719
2020-06-03 Yu Calvin Vice President, Finance Sale −1,043 $31.04 $32K 110,986
2020-06-03 Yu Calvin Vice President, Finance Sale −300 $32.02 $10K 110,686
2020-05-15 Paul Robert Chief Medical Officer Sale −1,900 $26.15 $50K 241,819
2020-05-15 Paul Robert Chief Medical Officer Sale −5,996 $27.00 $162K 235,823
2020-05-15 Paul Robert Chief Medical Officer Sale −2,104 $27.78 $58K 233,719
2020-05-15 King Robert Chief Development Officer Sale −3,365 $26.24 $88K 488,952
2020-05-15 King Robert Chief Development Officer Sale −8,632 $27.02 $233K 480,320
2020-05-15 King Robert Chief Development Officer Sale −3,003 $27.78 $83K 477,317
2020-05-11 Yaffe Kristine Director Grant or award · Stock Option (right to buy) +19,274 19,274
2020-05-11 Wehner David M. Director Grant or award · Stock Option (right to buy) +19,274 19,274
2020-05-11 SCHELLER RICHARD H Director Grant or award · Stock Option (right to buy) +19,274 19,274
2020-05-11 MCGUIRE TERRANCE Director Grant or award · Stock Option (right to buy) +19,274 19,274
2020-05-11 LAVIGNE LOUIS J JR Director Grant or award · Stock Option (right to buy) +19,274 19,274
2020-05-11 Gerngross Tillman U. Director Grant or award · Stock Option (right to buy) +19,274 19,274
2020-04-16 ORBIMED ADVISORS LLC 10% owner Sale −47,097 $23.53 $1.1M 5,955,674
2020-04-16 ORBIMED ADVISORS LLC 10% owner Sale −15,086 $23.53 $355K 1,906,718
2020-04-15 Paul Robert Chief Medical Officer Sale −10,000 $22.27 $223K 243,719
2020-04-14 ORBIMED ADVISORS LLC 10% owner Sale −17,595 $23.52 $414K 6,002,771
2020-04-14 ORBIMED ADVISORS LLC 10% owner Sale −5,636 $23.52 $133K 1,921,804

Page 24 of 36 · 702 trades